CONMED Corporation

NYSE:CNMD Stock Report

Market Cap: US$2.2b

CONMED Management

Management criteria checks 3/4

CONMED's CEO is Curt Hartman, appointed in Jul 2014, has a tenure of 10.33 years. total yearly compensation is $7.76M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth $6.66M. The average tenure of the management team and the board of directors is 5.8 years and 9.3 years respectively.

Key information

Curt Hartman

Chief executive officer

US$7.8m

Total compensation

CEO salary percentage12.2%
CEO tenure10.3yrs
CEO ownership0.3%
Management average tenure5.8yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

CEO Compensation Analysis

How has Curt Hartman's remuneration changed compared to CONMED's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$132m

Jun 30 2024n/an/a

US$99m

Mar 31 2024n/an/a

US$82m

Dec 31 2023US$8mUS$950k

US$64m

Sep 30 2023n/an/a

US$58m

Jun 30 2023n/an/a

US$88m

Mar 31 2023n/an/a

-US$94m

Dec 31 2022US$8mUS$946k

-US$81m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

US$68m

Dec 31 2021US$9mUS$918k

US$63m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$54m

Mar 31 2021n/an/a

US$13m

Dec 31 2020US$6mUS$888k

US$10m

Sep 30 2020n/an/a

US$311k

Jun 30 2020n/an/a

US$431k

Mar 31 2020n/an/a

US$34m

Dec 31 2019US$6mUS$842k

US$29m

Sep 30 2019n/an/a

US$29m

Jun 30 2019n/an/a

US$28m

Mar 31 2019n/an/a

US$31m

Dec 31 2018US$5mUS$791k

US$41m

Sep 30 2018n/an/a

US$72m

Jun 30 2018n/an/a

US$73m

Mar 31 2018n/an/a

US$71m

Dec 31 2017US$3mUS$753k

US$55m

Compensation vs Market: Curt's total compensation ($USD7.76M) is above average for companies of similar size in the US market ($USD5.36M).

Compensation vs Earnings: Curt's compensation has been consistent with company performance over the past year.

CEO

Curt Hartman (60 yo)

10.3yrs

Tenure

US$7,764,615

Compensation

Mr. Curt R. Hartman serves as the Director of CONMED Corporation since October 31, 2024 and Chief Executive Officer and President of CONMED Corporation since November 09, 2014, He served as Chairman of the...

Leadership Team

NamePositionTenureCompensationOwnership
Curt Hartman
President10.3yrsUS$7.76m0.30%
$ 6.7m
Todd Garner
Executive VP6.8yrsUS$2.87m0.00073%
$ 16.1k
Patrick Beyer
Chief Operating Officerless than a yearUS$3.30m0.035%
$ 769.3k
Richard Glaze
Chief Information Officerno datano datano data
Hollie Foust
General Counsel & Corporate Secretaryno datano datano data
Peter Shagory
Executive Vice President of Strategy & Corporate Development9.5yrsno data0.012%
$ 264.1k
Shanna Cotti-Osmanski
Executive VP of Information Technology & CIO4.7yrsno datano data
John Ferrell
Executive Vice President of Human Resources1.9yrsno data0.0023%
$ 49.9k
David Murray
President of ConMed Electrosurgery20.3yrsUS$572.33kno data
Johonna Pelletier
VP of Tax & Treasurer9.6yrsno data0.0043%
$ 93.7k
Kimberly Lockwood
Interim Corporate Controllerless than a yearno datano data

5.8yrs

Average Tenure

56yo

Average Age

Experienced Management: CNMD's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Curt Hartman
President10.7yrsUS$7.76m0.30%
$ 6.7m
John Workman
Independent Director9.3yrsUS$257.37k0.066%
$ 1.5m
David Bronson
Independent Director9.3yrsUS$264.87k0.054%
$ 1.2m
Brian Concannon
Independent Director11.3yrsUS$257.37k0.031%
$ 686.1k
LaVerne Council
Independent Director4.9yrsUS$257.37k0.012%
$ 254.0k
Martha Aronson
Independent Chair of the Board8.8yrsUS$292.37k0.045%
$ 990.5k
Charles Farkas
Independent Director10.3yrsUS$249.87k0.066%
$ 1.4m
Barbara Schwarzentraub
Independent Director5.2yrsUS$264.87k0.017%
$ 377.8k

9.3yrs

Average Tenure

64yo

Average Age

Experienced Board: CNMD's board of directors are considered experienced (9.3 years average tenure).